Skip to content
Interagency Autism Coordinating Committee (IACC)
Autism Research Database
Office of Autism Research Coordination (OARC)
 
Project Element Element Description

Project Title

Project Title

Double-blind placebo controlled trial of subcutaneous methyl B12 on behavioral and metabolic measures in children with autism

Principal Investigator

Principal Investigator

Hendren, Robert

Description

Description

Project description unavailable

Funder

Funder

Autism Speaks

Fiscal Year Funding

Fiscal Year Funding

150000

Current Award Period

Current Award Period

na

Strategic Plan Question

Strategic Plan Question

Question 4: Which Treatments And Interventions Will Help?

Strategic Plan Objective

Strategic Plan Objective

Yellow dot: Objective has some degree of funding, but less than the recommended amount. 4.8 Complete at least three randomized controlled trials on medications targeting core symptoms in people with ASD of all ages by 2014. IACC Recommended Budget: $22,200,000 over 5 years.

Project Link

Project Link

No link available.

Institution

Institution

University of California, Davis

State/Country

State/Country

California

Project Number

Project Number

3031

Federal or Private?

Federal or Private?

Private

Received ARRA Funding?

Received ARRA Funding?

No

History/Related Projects

History/Related Projects

Double-blind placebo controlled trial of subcutaneous methyl B12 on behavioral and metabolic measures in children with autism | 150000 | 2009 | 3031
Double-blind placebo controlled trial of subcutaneous methyl B12 on behavioral and metabolic measures in children with autism | 127500 | 2010 | 3031
Double-blind placebo controlled trial of subcutaneous methyl B12 on behavioral and metabolic measures in children with autismĀ  | 103536 | 2011 | 3031
Double-blind placebo controlled trial of subcutaneous methyl B12 on behavioral and metabolic measures in children with autismĀ  | 0 | 2012 | 3031

 
Back to Top